Drugs for Human Use; Drug Efficacy Study Implementation: Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination with a Sedative, and Single-Entity Antispasmodic Drug Products, in Oral Dosage Form

TitleDrugs for Human Use; Drug Efficacy Study Implementation: Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination with a Sedative, and Single-Entity Antispasmodic Drug Products, in Oral Dosage Form
ToC Doc Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination with a Sedative, and Single-Entity Antispasmodic Drug Products, in Oral Dosage Form
Docket Number2022-08740
Type Notice
Subject Drugs for Human Use; Drug Efficacy Study Implementation:
Oral Prescription Drugs Containing an Anticholinergic or Antispasmodic in Combination with a Sedative, and Single-Entity Antispasmodic Drug Products, in Oral Dosage Form
Publication Date2022-04-25
Last Updated Date 2022-04-22 08:15:06 -0400
Last Public Inspection2022-04-22
Filed At2022-04-22T08:45:00.000-04:00
PDF 2022-08740_PI.pdf (103953 bytes)
Download TXT / HTML / JSON
Number of Pages 7
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021